{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:09:16Z","timestamp":1769897356523,"version":"3.49.0"},"reference-count":264,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Until the advent of modern neuroradiological imaging techniques in 1989, a diagnosis of GH deficiency in adults carried little significance other than as a marker of hypothalamo-pituitary disease. The relatively recent recognition of a characteristic clinical syndrome associated with failure of spontaneous GH secretion and the potential reversal of many of its features with recombinant human GH has prompted a closer examination of the physiological role of GH after linear growth is complete. The safe clinical practice of GH replacement demands a method of judging overall GH status, but there is no biological marker in adults that is the equivalent of linear growth in a child by which to judge the efficacy of GH replacement. Assessment of optimal GH replacement is made difficult by the apparent diverse actions of GH in health, concern about the avoidance of iatrogenic acromegaly, and the growing realization that an individual\u2019s risk of developing certain cancers may, at least in part, be influenced by cumulative exposure to the chief mediator of GH action, IGF-I. As in all areas of clinical practice, strategies and protocols vary between centers, but most physicians experienced in the management of pituitary disease agree that GH is most appropriately begun at low doses, building up slowly to the final maintenance dose. This, in turn, is best determined by a combination of clinical response and measurement of serum IGF-I, avoiding supraphysiological levels of this GH-dependent peptide. Numerous studies have helped define the optimum management of GH replacement during childhood. The recent requirement to measure and monitor GH status in adult life has called into question the appropriateness of simplistic weight- and surface area-based dosing regimens for the management of GH deficiency in childhood, with reliance on linear growth as the sole marker of GH action. It is clear that the monitoring of parameters other than linear growth to help refine GH therapy should now be incorporated into childhood GH treatment protocols. Further research will be required to define the optimal management of the transition from pediatric to adult GH replacement; this transition will only be possible once the benefits of GH in mature adults are defined and accepted by pediatric and adult endocrinologists alike.<\/jats:p>","DOI":"10.1210\/edrv.22.4.0438","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T18:26:28Z","timestamp":1389205588000},"page":"425-450","source":"Crossref","is-referenced-by-count":102,"title":["Optimizing GH Therapy in Adults and Children"],"prefix":"10.1210","volume":"22","author":[{"given":"W. M.","family":"Drake","sequence":"first","affiliation":[{"name":"Departments of Endocrinology, St. Bartholomew\u2019s Hospital, London EC1A 7BE, United Kingdom; and Christie Hospital, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Howell","sequence":"first","affiliation":[{"name":"Departments of Endocrinology, St. Bartholomew\u2019s Hospital, London EC1A 7BE, United Kingdom; and Christie Hospital, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Monson","sequence":"first","affiliation":[{"name":"Departments of Endocrinology, St. Bartholomew\u2019s Hospital, London EC1A 7BE, United Kingdom; and Christie Hospital, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Shalet","sequence":"first","affiliation":[{"name":"Departments of Endocrinology, St. Bartholomew\u2019s Hospital, London EC1A 7BE, United Kingdom; and Christie Hospital, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2020071612080004500_R1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH deficient adults.","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"2020071612080004500_R2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"2020071612080004500_R3","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency\u2014results of a 13-month placebo controlled cross-over study.","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R7","first-page":"379","article-title":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R8","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.84.21.7686","article-title":"The pituitary-gland secretes in bursts\u2014appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma-hormone concentrations.","volume":"84","author":"Veldhuis","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612080004500_R9","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.","volume":"19","author":"Guistina","year":"1998","journal-title":"Endocr Rev"},{"key":"2020071612080004500_R10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release.","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"key":"2020071612080004500_R11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth hormone-releasing acylated peptide from stomach.","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"2020071612080004500_R12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo-115-5-1952","article-title":"The interrelationship of growth hormone (GH)-releasing factor and somatostatin in the generation of the ultradian rhythm of GH secretion.","volume":"115","author":"Tannenbaum","year":"1984","journal-title":"Endocrinology"},{"key":"2020071612080004500_R13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jcem-62-1-134","article-title":"A specific growth hormone-binding protein in human plasma: initial characterization.","volume":"62","author":"Baumann","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1210\/jcem-70-3-680","article-title":"A second, lower affinity growth hormone-binding protein in human plasma.","volume":"70","author":"Baumann","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1549776","article-title":"Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.","volume":"255","author":"de Vos","year":"1992","journal-title":"Science"},{"key":"2020071612080004500_R16","first-page":"123","article-title":"Abdominal fat determines growth hormone binding protein levels in healthy nonobese adults.","volume":"82","author":"Fisker","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/endo.137.3.8603568","article-title":"Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat.","volume":"137","author":"Gevers","year":"1996","journal-title":"Endocrinology"},{"key":"2020071612080004500_R18","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/jcem-70-6-1678","article-title":"Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion.","volume":"70","author":"Winer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R19","first-page":"1312","article-title":"Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women.","volume":"78","author":"Chapman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R20","first-page":"1706","article-title":"Growth hormone secretion in recently operated acromegalic patients.","volume":"79","author":"van den Berg,","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R21","author":"Jaffe","year":"1995"},{"key":"2020071612080004500_R22","first-page":"1589","article-title":"Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects.","volume":"77","author":"Jorgensen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R23","first-page":"2410","article-title":"Continuous infusion vs. daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.","volume":"80","author":"Laursen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R24","first-page":"1135","article-title":"Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children.","volume":"76","author":"Tauber","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1651-2227.1987.tb17138.x","article-title":"The effect of human growth hormone injection frequency on linear growth rate.","volume":"337","author":"Albertsson-Wikland","year":"1987","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2020071612080004500_R26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1677\/joe.0.1190179","article-title":"Growth and growth hormone secretion.","volume":"119","author":"Brook","year":"1988","journal-title":"J Endocrinol"},{"key":"2020071612080004500_R27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.72.5.427","article-title":"Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.","volume":"72","author":"Boersma","year":"1995","journal-title":"Arch Dis Child"},{"key":"2020071612080004500_R28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-291X(88)90570-0","article-title":"Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor-I.","volume":"151","author":"Ernst","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612080004500_R29","first-page":"2460","article-title":"An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.","volume":"81","author":"van den Berg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.81.3.935","article-title":"Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.","volume":"81","author":"D\u2019Ercole","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612080004500_R31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9343(80)90470-2","article-title":"Estradiol treatment of acromegaly: reduction of immunoreactive somatomedin C and improvement of metabolic status.","volume":"69","author":"Clemmons","year":"1980","journal-title":"Am J Med"},{"key":"2020071612080004500_R32","first-page":"4268","article-title":"Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.","volume":"81","author":"Goodman-Gruen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-72-2-374","article-title":"Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.","volume":"72","author":"Weissberger","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R34","first-page":"2250","article-title":"Both oral and transdermal estrogen increase growth hormone release in postmenopausal women\u2014a clinical research center study.","volume":"81","author":"Friend","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-64-1-51","article-title":"Effects of sex and age on the 24-hour profile of growth-hormone secretion in man\u2014importance of endogenous estradiol concentrations.","volume":"64","author":"Ho","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.1987.tb03645.x","article-title":"Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone\u2014evidence for a direct effect of growth hormone.","volume":"26","author":"Ross","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1677\/joe.0.1470225","article-title":"Hypothalamic GH receptor gene expression in the rat\u2014effects of altered GH status.","volume":"147","author":"Bennett","year":"1995","journal-title":"J Endocrinol"},{"key":"2020071612080004500_R38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.6262917","article-title":"Somatomedin C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.","volume":"212","author":"Berelowitz","year":"1981","journal-title":"Science"},{"key":"2020071612080004500_R39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem-60-3-513","article-title":"The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals.","volume":"60","author":"Zadik","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000124682","article-title":"Decreased stimulation of adenylate cyclase by growth hormone releasing factor in the anterior pituitary of old rats.","volume":"44","author":"Robberecht","year":"1986","journal-title":"Neuroendocrinology"},{"key":"2020071612080004500_R42","first-page":"Karger","article-title":"Decline in GH secretion in aging animals and man","volume":"Switzerland","author":"Sonntag","year":"1988","journal-title":"In: Everett AV, Walton JR, eds. Regulation of neuroendocrine aging. Basel,"},{"key":"2020071612080004500_R43","first-page":"530","article-title":"Growth hormone (GH)-releasing hormone-(1\u201329) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.","volume":"75","author":"Corpas","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03347707","article-title":"Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration.","volume":"17","author":"Ghigo","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"2020071612080004500_R45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0300-595X(84)80011-0","article-title":"Factors controlling blood concentration of somatomedin C.","volume":"13","author":"Clemmons","year":"1984","journal-title":"Clin Endocrinol Metab"},{"key":"2020071612080004500_R46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/geronj\/40.1.2","article-title":"Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone.","volume":"40","author":"Florini","year":"1985","journal-title":"J Gerontol"},{"key":"2020071612080004500_R47","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI110164","article-title":"Impaired growth hormone secretion in the adult population: relation to age and adiposity.","volume":"67","author":"Rudman","year":"1981","journal-title":"J Clin Invest"},{"key":"2020071612080004500_R48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0026-0495(90)90022-5","article-title":"The relationship between insulin-like growth factor-I, adiposity, and aging.","volume":"39","author":"Copeland","year":"1990","journal-title":"Metab Clin Exp"},{"key":"2020071612080004500_R49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1651-2227.1986.tb10163.x","article-title":"Daily subcutaneous administration of human growth hormone in growth hormone deficient children.","volume":"75","author":"Albertsson-Wikland","year":"1986","journal-title":"Acta Paediat Scand"},{"key":"2020071612080004500_R50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/acta.0.1160381","article-title":"Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.","volume":"116","author":"Jorgensen","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"Suppl 2","key":"2020071612080004500_R51","first-page":"1","article-title":"Absorption of injected insulin","volume":"27","author":"Binder","year":"1989","journal-title":"Acta Pharmacol Toxicol"},{"key":"2020071612080004500_R52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1530\/acta.0.1180154","article-title":"Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients.","volume":"118","author":"Jorgensen","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R53","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/endo-122-6-2920","article-title":"Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine.","volume":"122","author":"Moore","year":"1988","journal-title":"Endocrinology"},{"key":"2020071612080004500_R54","first-page":"213","article-title":"The absorption kinetics of subcutaneously administered growth hormone: influence of injection volume.","volume":"3","author":"Jorgensen","year":"1989","journal-title":"J Paediat Endocrinol Metab"},{"key":"2020071612080004500_R55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1210\/jcem-18-8-901","article-title":"Treatment of a pituitary dwarf with human growth hormone.","volume":"18","author":"Raben","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00441309","article-title":"Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone.","volume":"137","author":"Burns","year":"1981","journal-title":"Eur J Pediatr"},{"key":"2020071612080004500_R57","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1203\/00006450-198308000-00015","article-title":"Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy.","volume":"17","author":"Joss","year":"1983","journal-title":"Pediatr Res"},{"key":"2020071612080004500_R58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/acta.0.1200409","article-title":"Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation, Japan.","volume":"120","author":"Hibi","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jcem-63-2-376","article-title":"Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty.","volume":"63","author":"Bourguignon","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJM198509193131206","article-title":"Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.","volume":"313","author":"Koch","year":"1985","journal-title":"N Engl J Med"},{"key":"2020071612080004500_R61","first-page":"161","article-title":"A novel enzymatic method for production of authentic hGH from an Escherichia coli produced hGH precursor.","volume":"5","author":"Dalboge","year":"1987","journal-title":"Biotechnology"},{"key":"2020071612080004500_R62","first-page":"531","article-title":"Biochemical tests in the diagnosis of childhood growth hormone deficiency.","volume":"82","author":"Tillmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R63","first-page":"1532","article-title":"Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited.","volume":"80","author":"Rosenfeld","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000023298","article-title":"Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27\u201328 march 1998.","volume":"50","author":"Saggese","year":"1998","journal-title":"Horm Res"},{"key":"2020071612080004500_R65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2265.1996.671492.x","article-title":"The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood.","volume":"44","author":"Nicolson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.82.2.3734","article-title":"Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group.","volume":"82","author":"Blethen","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R67","first-page":"452","article-title":"A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.","volume":"82","author":"Rappaport","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1542\/peds.102.S3.512","article-title":"Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: The National Cooperative Growth Study experience.","volume":"102","author":"August","year":"1998","journal-title":"Pediatrics"},{"key":"2020071612080004500_R69","first-page":"918","article-title":"Hypoglycemia in hypopituitary children.","volume":"129","author":"Hopwood","year":"1975","journal-title":"Am J Dis Child"},{"key":"2020071612080004500_R70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.102.S3.527","article-title":"Current dosing of growth hormone in children with growth hormone deficiency: how physiologic?","volume":"102","author":"MacGillivray","year":"1998","journal-title":"Pediatrics"},{"key":"2020071612080004500_R71","first-page":"336","article-title":"Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass.","volume":"74","author":"Martha Jr","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem-40-2-240","article-title":"Circadian variation of integrated concentration of growth hormone in children and adults.","volume":"40","author":"Plotnick","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/jcem-38-3-436","article-title":"Integrated concentrations of growth hormone correlated with stage of puberty and estrogen levels in girls.","volume":"38","author":"Plotnick","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-32-3-356","article-title":"Determination of integrated plasma concentrations and true secretion rates of human growth hormone.","volume":"32","author":"Kowarski","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R75","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jcem-30-5-632","article-title":"Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth.","volume":"30","author":"MacGillivray","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1651-2227.1987.tb17134.x","article-title":"An attempt to assess the replacement dose of human growth hormone in the treatment of growth hormone deficient children.","volume":"337","author":"Hibi","year":"1987","journal-title":"Acta Paediat Scand Suppl"},{"key":"2020071612080004500_R77","author":"Quigley","year":"2000"},{"key":"2020071612080004500_R78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2000.01105.x","article-title":"monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3) IGF-I\/IGFBP3 molar ratio and leptin during growth hormone treatment for disordered growth.","volume":"52","author":"Tillman","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1210\/jcem-53-6-1213","article-title":"A dose-response curve for human growth hormone.","volume":"53","author":"Frasier","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1651-2227.1984.tb09909.x","article-title":"The dosage dependency of growth and maturity in growth hormone deficiency treated with human growth hormone.","volume":"73","author":"Vicens-Calvet","year":"1984","journal-title":"Acta Paediatr Scand"},{"key":"2020071612080004500_R81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1651-2227.1991.tb12059.x","article-title":"Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.","volume":"379","author":"Ranke","year":"1991","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2020071612080004500_R82","first-page":"574","article-title":"Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency.","volume":"76","author":"Blethen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R83","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1530\/acta.0.1040148","article-title":"Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.","volume":"104","author":"Kastrup","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000181590","article-title":"Frequency of administration of growth hormone\u2013an important factor in determining growth response to exogenous growth hormone.","volume":"33","author":"Hindmarsh","year":"1990","journal-title":"Horm Res"},{"key":"2020071612080004500_R85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/adc.63.5.491","article-title":"Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.","volume":"63","author":"Smith","year":"1988","journal-title":"Arch Dis Child"},{"key":"2020071612080004500_R86","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1651-2227.1998.tb01496.x","article-title":"Once vs. twice daily injections of growth hormone in children with idiopathic short stature.","volume":"87","author":"Phillip","year":"1998","journal-title":"Acta Paediatr"},{"key":"2020071612080004500_R87","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jcem.84.12.6189","article-title":"Four decades of growth hormone therapy for short children: what have we achieved?","volume":"84","author":"Guyda","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1651-2227.1999.tb14356.x","article-title":"Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.","volume":"88","author":"Cutfield","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000184259","article-title":"Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone. Dutch Growth Hormone Working Group.","volume":"43","author":"Rikken","year":"1995","journal-title":"Horm Res"},{"key":"2020071612080004500_R90","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.315.7110.708","article-title":"Long-term results of growth hormone treatment in France in children of short stature: population, register based study.","volume":"315","author":"Coste","year":"1997","journal-title":"Br Med J"},{"key":"2020071612080004500_R91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.0.1370053","article-title":"Final height of patients treated for isolated GH deficiency: examination of 83 patients.","volume":"137","author":"Cacciari","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R92","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000184260","article-title":"Final height in children with growth hormone deficiency.","volume":"43","author":"Severi","year":"1995","journal-title":"Horm Res"},{"key":"2020071612080004500_R93","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1096-6374(98)80164-0","article-title":"Dose response effects of hGH on auxological and biochemical parameters in GH deficient children: a randomised three dose study in 110 children.","volume":"8","author":"Cohen","year":"1998","journal-title":"Growth Horm IGF Res"},{"key":"2020071612080004500_R94","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.1999.tb14357.x","article-title":"High-dose growth hormone (GH) treatment in prepubertal GH-deficient children.","volume":"88","author":"Yokoya","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R95","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of children with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Growth Hormone Deficiency in Childhood.","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R96","first-page":"27","article-title":"Pubertal growth in patients with idiopathic growth hormone deficiency.","volume":"10","author":"Ranke","year":"1993","journal-title":"KIGS Biannual Report"},{"key":"2020071612080004500_R97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000182563","article-title":"The effects of growth hormone therapy on spontaneous sexual development.","volume":"38","author":"Stanhope","year":"1992","journal-title":"Horm Res"},{"key":"2020071612080004500_R98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1651-2227.1999.tb14358.x","article-title":"Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.","volume":"88","author":"Albertsson Wikland","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R99","first-page":"546","article-title":"Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years.","volume":"80","author":"Paul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004310050831","article-title":"Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.","volume":"157","author":"Bertelloni","year":"1998","journal-title":"Eur J Pediatr"},{"key":"2020071612080004500_R101","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated vs. treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"key":"2020071612080004500_R102","first-page":"299","article-title":"Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis.","volume":"84","author":"Saggese","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R103","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1210\/jcem.84.2.5431","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone [published erratum appears in J Clin Endocrinol Metab 1999;84(6):1978].","volume":"84","author":"Pasquino","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R104","first-page":"229","article-title":"Adult height in 24 patients treated for growth hormone deficiency and early puberty.","volume":"82","author":"Adan","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1651-2227.1999.tb00183.x","article-title":"Growth hormone treatment during suppression of early puberty in adopted girls. Swedish Growth Hormone Advisory Group.","volume":"88","author":"Tuvemo","year":"1999","journal-title":"Acta Paediatr"},{"key":"2020071612080004500_R106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2265.1998.00499.x","article-title":"Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.","volume":"49","author":"Lanes","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000183889","article-title":"Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist.","volume":"41","author":"Job","year":"1994","journal-title":"Horm Res"},{"key":"2020071612080004500_R108","first-page":"3596","article-title":"Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.","volume":"80","author":"Balducci","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R109","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/acta.0.1200795","article-title":"The effects of treatment combining an agonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency.","volume":"120","author":"Toublanc","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/acta.0.1270307","article-title":"Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency.","volume":"127","author":"Saggese","year":"1992","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R111","first-page":"569","article-title":"Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.","volume":"85","author":"Mericq","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1651-2227.1999.tb14359.x","article-title":"When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.","volume":"88","author":"Tanaka","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R113","first-page":"16","author":"Otten","year":"1992"},{"key":"2020071612080004500_R114","author":"Wilton","year":"1999"},{"key":"2020071612080004500_R115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3476(95)70232-6","article-title":"Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.","volume":"126","author":"Malozowski","year":"1995","journal-title":"J Pediatr"},{"key":"2020071612080004500_R116","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(95)70372-1","article-title":"Prepubertal gynecomastia during growth hormone therapy [published erratum appears in J Pediatr 1995; 127(1):159].","volume":"126","author":"Malozowski","year":"1995","journal-title":"J Pediatr"},{"key":"2020071612080004500_R117","first-page":"1704","article-title":"Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience.","volume":"81","author":"Blethen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1651-2227.1998.tb01463.x","article-title":"Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand.","volume":"87","author":"Crock","year":"1998","journal-title":"Acta Paediatr"},{"key":"2020071612080004500_R119","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","article-title":"Risk of leukemia in children treated with human growth hormone: review and reanalysis","volume":"131","author":"Allen","year":"1997","journal-title":"J Pediatr"},{"key":"2020071612080004500_R120","first-page":"29","author":"Shalet","year":"1997"},{"key":"2020071612080004500_R121","first-page":"236","article-title":"Carbohydrate metabolism on high dose growth hormone therapy in children treated for leukaemia.","volume":"25","author":"Crawford","year":"1989","journal-title":"Aust Paediatr J"},{"key":"2020071612080004500_R122","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-3476(05)80959-X","article-title":"Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone.","volume":"123","author":"Botero","year":"1993","journal-title":"J Pediatr"},{"key":"2020071612080004500_R123","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"2020071612080004500_R124","first-page":"396","article-title":"Slipped capital femoral epiphysis in growth hormone-deficient patients.","volume":"139","author":"Rappaport","year":"1985","journal-title":"Am J Dis Child"},{"key":"2020071612080004500_R125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults.","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071612080004500_R126","author":"Ranke","year":"1994"},{"key":"2020071612080004500_R127","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.","volume":"84","author":"Ranke","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R128","first-page":"1922","article-title":"Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.","volume":"80","author":"Fujimoto","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/eje.0.1400035","article-title":"Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.","volume":"140","author":"Matsuoka","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R130","first-page":"2735","article-title":"Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment.","volume":"83","author":"Kristrom","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000184257","article-title":"Approaching final height in children treated for growth hormone deficiency.","volume":"43","author":"Chipman","year":"1995","journal-title":"Horm Res"},{"key":"2020071612080004500_R132","first-page":"374","article-title":"Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.","volume":"80","author":"Schoenle","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mpd.2000.105369","article-title":"Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.","volume":"137","author":"Myers","year":"2000","journal-title":"J Pediatr"},{"key":"2020071612080004500_R134","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s004310051246","article-title":"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome.","volume":"158","author":"Lindgren","year":"1999","journal-title":"Eur J Pediatr"},{"key":"2020071612080004500_R135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3476(99)70418-X","article-title":"Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study.","volume":"134","author":"Carrel","year":"1999","journal-title":"J Pediatr"},{"key":"2020071612080004500_R136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM196201112660207","article-title":"Clinical use of human growth hormone.","volume":"266","author":"Raben","year":"1962","journal-title":"N Engl J Med"},{"key":"2020071612080004500_R137","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"2020071612080004500_R138","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism.","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"2020071612080004500_R141","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1995.tb01908.x","article-title":"Which adults develop side-effects of growth hormone replacement?","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R142","first-page":"1671","article-title":"Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.","volume":"77","author":"Amato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R143","first-page":"1371","article-title":"Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.","volume":"81","author":"de Boer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R144","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1993.tb00974.x","article-title":"Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency.","volume":"38","author":"Rosen","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R145","first-page":"211","author":"Goodman","year":"1974"},{"key":"2020071612080004500_R146","first-page":"187","author":"Kostyo","year":"1974"},{"key":"2020071612080004500_R147","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body.","volume":"41","author":"Lukaski","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"2020071612080004500_R148","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ajcn\/41.2.363","article-title":"A simple, inexpensive method of determining total body water using a tracer dose of D2O and infrared absorption of biological fluids.","volume":"41","author":"Lukaski","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"2020071612080004500_R149","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1088\/0031-9155\/24\/1\/016","article-title":"Total body potassium calibrations for normal and obese subjects in two types of whole body counter.","volume":"24","author":"Smith","year":"1979","journal-title":"Phys Med Biol"},{"key":"2020071612080004500_R150","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/51.6.1106","article-title":"Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition.","volume":"51","author":"Mazess","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"2020071612080004500_R151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1079\/BJN19740060","article-title":"Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.","volume":"32","author":"Durnin","year":"1974","journal-title":"Br J Nutr"},{"key":"2020071612080004500_R152","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365517809108434","article-title":"Cross-sectional area of the thigh muscle in man measured by computed tomography.","volume":"38","author":"Haggmark","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"2020071612080004500_R153","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/cs0430469","article-title":"A comparison of the fat-free mass of young adults estimated by anthropometry, body density and total body potassium content.","volume":"43","author":"Womersley","year":"1972","journal-title":"Clin Sci"},{"key":"2020071612080004500_R154","first-page":"30","article-title":"Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders.","volume":"128","author":"Brummer","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R155","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R156","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R157","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.","volume":"82","author":"Christ","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R158","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults.","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R159","first-page":"223","article-title":"Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.","volume":"82","author":"Thoren","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R161","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","article-title":"Decreased psychological well-being in adult patients with growth hormone deficiency.","volume":"40","author":"Rosen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R162","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/jcem.80.12.8530603","article-title":"Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.","volume":"80","author":"Burman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R163","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0271-7123(81)90005-5","article-title":"The Nottingham Health Profile: subjective health status and medical consultations.","volume":"15","author":"Hunt","year":"1981","journal-title":"Social Science & Medicine - Part A, Medical Sociology"},{"key":"2020071612080004500_R164","first-page":"170","article-title":"The psychological general well-being (PGWB) index","volume":"York","author":"Dupuy","year":"1984","journal-title":"In: Wenger NK (ed) Association of quality of life in clinical trials of cardiovascular therapies. New"},{"key":"2020071612080004500_R165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000181584","article-title":"Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.","volume":"33","author":"McGauley","year":"1990","journal-title":"Horm Res"},{"key":"2020071612080004500_R166","first-page":"3184","article-title":"Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.","volume":"83","author":"Baum","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R167","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.1995.tb02688.x","article-title":"Characteristics of adults who wish to enter a trial of growth hormone replacement.","volume":"42","author":"Holmes","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R168","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1995.tb01909.x","article-title":"Factors influencing the desire for long-term growth hormone replacement in adults.","volume":"43","author":"Holmes","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R169","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2265.1997.3041112.x","article-title":"Two years of replacement therapy in adults with growth hormone deficiency.","volume":"47","author":"Verhelst","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1530\/eje.0.1370146","article-title":"The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.","volume":"137","author":"Carroll","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R171","first-page":"37","article-title":"Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency.","volume":"128","author":"Hunt","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R172","first-page":"420","article-title":"The development of the AGHDA score: a measure to assess quality of life of adults with growth hormone deficiency.","volume":"4","author":"Doward","year":"1995","journal-title":"Qual Life Res"},{"key":"2020071612080004500_R173","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency.","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res"},{"key":"2020071612080004500_R174","author":"Wiren","year":"1996"},{"key":"2020071612080004500_R175","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R176","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1210\/endo-118-5-1843","article-title":"Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture.","volume":"118","author":"Lindahl","year":"1986","journal-title":"Endocrinology"},{"key":"2020071612080004500_R177","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1073\/pnas.83.20.7932","article-title":"Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin.","volume":"83","author":"Schlechter","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612080004500_R178","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency.","volume":"78","author":"Holmes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R179","first-page":"118","article-title":"Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.","volume":"74","author":"Kaufman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.","volume":"137","author":"Rosen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R181","first-page":"1919","article-title":"Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R182","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1677\/joe.0.116R011","article-title":"Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells","volume":"116","author":"Slootweg","year":"1988","journal-title":"J Endocrinol"},{"key":"2020071612080004500_R183","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/pgmj.69.817.846","article-title":"New markers of bone and collagen turnover in children and adults with growth hormone deficiency.","volume":"69","author":"Sartorio","year":"1993","journal-title":"Postgrad Med J"},{"key":"2020071612080004500_R184","first-page":"41","article-title":"Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency.","volume":"2","author":"Thoren","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071612080004500_R185","first-page":"1344","article-title":"Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency.","volume":"76","author":"O\u2019Halloran","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R186","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2265.1993.tb02387.x","article-title":"Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.","volume":"39","author":"Vandeweghe","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R187","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","volume":"125","author":"Baum","journal-title":"Ann Intern Med"},{"key":"2020071612080004500_R188","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R189","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The effect of long term GH replacement on bone mineral density and metabolism in hypopituitary adults.","volume":"54","author":"Drake","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R190","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/jcem-70-4-916","article-title":"Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.","volume":"70","author":"Johansen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R191","first-page":"2002","article-title":"Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency.","volume":"84","author":"Johansson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R192","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00571329","article-title":"Serum bone Gla protein as a marker of bone turnover in acromegaly.","volume":"52","author":"Marazuela","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2020071612080004500_R193","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF00298716","article-title":"Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.","volume":"52","author":"Terzolo","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2020071612080004500_R194","author":"Bouillon","year":"1998"},{"key":"2020071612080004500_R195","first-page":"552","article-title":"Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.","volume":"80","author":"Nass","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R196","first-page":"4570","article-title":"Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.","volume":"84","author":"Woodhouse","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R197","first-page":"279","article-title":"Changes in muscle volume, strength and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.","volume":"84","author":"Janssen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R198","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/hrt.67.1.92","article-title":"Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality.","volume":"67","author":"Shahi","year":"1992","journal-title":"Br Heart J"},{"key":"2020071612080004500_R199","first-page":"E219","article-title":"Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement","volume":"267","author":"Cittadini","year":"1994","journal-title":"Am J Physiol"},{"key":"2020071612080004500_R200","first-page":"119","article-title":"The effects of low dose recombinant human growth hormone on cardiovascular structure and function in hypopituitary growth hormone deficient adults.","volume":"2","author":"Fort","year":"1995","journal-title":"Endocrinol Metab"},{"key":"2020071612080004500_R201","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/edrv-15-5-555","article-title":"Growth hormone and the heart.","volume":"15","author":"Sacca","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071612080004500_R202","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly.","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"2020071612080004500_R203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.2000.01108.x","article-title":"Sustained reduction in circulating cholesterol in hypopituitary patients given low dose titrated growth hormone replacement: a two year study.","volume":"53","author":"Florakis","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R204","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"2020071612080004500_R205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/90.12.911","article-title":"Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.","volume":"90","author":"Wolk","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2020071612080004500_R206","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"2020071612080004500_R207","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.1999.00722.x","article-title":"Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.","volume":"50","author":"Murray","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R208","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth-hormone deficiency in adults [published erratum appears in Lancet 1994; 344(8916):206].","volume":"343","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"key":"2020071612080004500_R209","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/endo-123-6-2605","article-title":"Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.","volume":"123","author":"Isgaard","year":"1988","journal-title":"Endocrinology"},{"key":"2020071612080004500_R210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2265.1997.d01-1740.x","article-title":"Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.","volume":"46","author":"Oscarsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R211","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.2000.00910.x","article-title":"Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults.","volume":"52","author":"Lucidi","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem.83.2.4545","article-title":"A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.","volume":"83","author":"Lucidi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2362.1993.tb00762.x","article-title":"Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy.","volume":"23","author":"Brummer","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"2020071612080004500_R214","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R215","first-page":"3956","article-title":"Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults.","volume":"84","author":"Cook","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R216","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men.","volume":"43","author":"de Boer","year":"1994","journal-title":"Metab Clin Exp"},{"key":"2020071612080004500_R217","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2020071612080004500_R218","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R219","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"2020071612080004500_R220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","article-title":"Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults.","volume":"136","author":"Markussis","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R221","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0140-6736(93)92664-F","article-title":"Aortic distensibility in growth hormone deficient adults.","volume":"341","author":"Lehmann","year":"1993","journal-title":"Lancet"},{"key":"2020071612080004500_R222","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","article-title":"Cardiovascular and renal effects of growth hormone.","volume":"40","author":"Caidahl","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R223","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3181\/00379727-79-19454","article-title":"Reduction of urinary sodium and potassium produced by hypohyseal growth hormoen in normal female rats.","volume":"79","author":"Whitney","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612080004500_R224","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1054\/ghir.2000.0134","article-title":"Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults.","volume":"10","author":"Wieringa","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"2020071612080004500_R225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1530\/eje.0.1400174","article-title":"Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement.","volume":"140","author":"Leese","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071612080004500_R226","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/diab.15.1.24","article-title":"Carbohydrate metabolism in hyperadrenocorticism.","volume":"15","author":"Aguiar Pupo","year":"1966","journal-title":"Diabetes"},{"key":"2020071612080004500_R227","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0300-595X(85)80083-9","article-title":"Cushing\u2019s syndrome.","volume":"14","author":"Howlett","year":"1985","journal-title":"Clinics Endocrinol Metab"},{"key":"2020071612080004500_R228","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2265.1981.tb00634.x","article-title":"Patterns of plasma cortisol and ACTH concentrations in patients with Addison\u2019s disease treated with conventional corticosteroid replacement.","volume":"14","author":"Feek","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R229","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2265.1997.87897.x","article-title":"The assessment of glucocorticoid replacement therapy.","volume":"46","author":"Monson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","article-title":"The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.","volume":"41","author":"Weaver","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R231","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1998.3641180.x","article-title":"The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11\u03b2-hydroxysteroid dehydrogenase activity.","volume":"48","author":"Gelding","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R232","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(71)90947-0","article-title":"Preclinical hypothyroidism: a risk factor for coronary heart-disease.","volume":"1","author":"Bastenie","year":"1971","journal-title":"Lancet"},{"key":"2020071612080004500_R233","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071612080004500_R234","first-page":"3097","article-title":"The diagnosis of growth hormone deficiency (GHD) in adults.","volume":"80","author":"Thorner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1096-6374(98)80047-6","article-title":"Growth hormone replacement therapy during transition of patients with childhood-onset growth hormone deficiency into adulthood: what are the issues?","volume":"8","author":"Shalet","year":"1998","journal-title":"Growth Horm IGF Res"},{"key":"2020071612080004500_R236","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/adc.62.3.222","article-title":"Growth hormone state after completion of treatment with growth hormone.","volume":"62","author":"Clayton","year":"1987","journal-title":"Arch Dis Child"},{"key":"2020071612080004500_R237","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jcem.82.2.3726","article-title":"Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment.","volume":"82","author":"Tauber","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R238","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2265.1996.00850.x","article-title":"Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth.","volume":"45","author":"Wacharasindhu","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R239","first-page":"1244","article-title":"Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood.","volume":"81","author":"Longobardi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R240","first-page":"1284","article-title":"Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient.","volume":"74","author":"Cacciari","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R241","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2265.1991.tb00327.x","article-title":"Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults.","volume":"34","author":"Rutherford","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R242","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000182734","article-title":"Discontinuation of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance.","volume":"39","author":"Colle","year":"1993","journal-title":"Horm Res"},{"key":"2020071612080004500_R243","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1210\/jcem.82.7.4101","article-title":"Why retest young adults with childhood-onset growth hormone deficiency?","volume":"82","author":"de Boer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R244","first-page":"4516","article-title":"Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.","volume":"84","author":"Johannsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R245","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.","volume":"85","author":"Vahl","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R246","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1210\/jcem.85.5.6613","article-title":"Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.","volume":"85","author":"Norrelund","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R247","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jbmr.5650090822","article-title":"Consequences of childhood-onset growth hormone deficiency for adult bone mass.","volume":"9","author":"de Boer","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071612080004500_R248","first-page":"970","article-title":"Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.","volume":"85","author":"Biller","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R249","first-page":"3077","article-title":"The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.","volume":"81","author":"Saggese","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R250","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3476(82)80093-0","article-title":"Psychosocial aspects of constitutional short stature: social competence, behavior problems, self-esteem, and family functioning.","volume":"101","author":"Gordon","year":"1982","journal-title":"J Pediatr"},{"key":"2020071612080004500_R251","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0031-3955(16)36290-3","article-title":"Psychosocial correlates of short stature and delayed puberty.","volume":"34","author":"Lee","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"2020071612080004500_R252","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpedi.1997.02170470051010","article-title":"Psychosocial outcome of children evaluated for short stature.","volume":"151","author":"Zimet","year":"1997","journal-title":"Arch Pediatr Adoles Med"},{"key":"2020071612080004500_R253","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.75.1.25","article-title":"Short stature\u2014the role of intelligence in psychosocial adjustment.","volume":"75","author":"Gilmour","year":"1996","journal-title":"Arch Dis Child"},{"key":"2020071612080004500_R254","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1542\/peds.94.6.832","article-title":"Short stature: a psychosocial burden requiring growth hormone therapy?","volume":"94","author":"Sandberg","year":"1994","journal-title":"Pediatrics"},{"key":"2020071612080004500_R255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.1994.tb13413.x","article-title":"Psychosocial assessment of children with short stature: a preliminary report.","volume":"406","author":"Skuse","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R256","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-3476(00)90057-X","article-title":"Is short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature.","volume":"136","author":"Kranzler","year":"2000","journal-title":"J Pediatr"},{"key":"2020071612080004500_R257","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.314.7074.97","article-title":"Are short normal children at a disadvantage? The Wessex growth study.","volume":"314","author":"Downie","year":"1997","journal-title":"Br Med J"},{"key":"2020071612080004500_R258","first-page":"2423","article-title":"Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.","volume":"82","author":"Boot","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R259","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1210\/jcem.83.9.5072","article-title":"Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency.","volume":"83","author":"Baroncelli","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.1994.tb13274.x","article-title":"Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report.","volume":"399","author":"Ogle","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"2020071612080004500_R261","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.bjc.6690296","article-title":"Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.","volume":"79","author":"Brennan","year":"1999","journal-title":"Br J Cancer"},{"key":"2020071612080004500_R262","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2265.1997.1660984.x","article-title":"The safety profile of GH replacement therapy in adults.","volume":"46","author":"Chipman","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612080004500_R263","first-page":"2069","article-title":"The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.","volume":"80","author":"de Boer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612080004500_R264","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2265.1993.tb02386.x","article-title":"Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.","volume":"39","author":"Moller","year":"1993","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/22\/4\/425\/8860184\/edrv0425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/22\/4\/425\/8860184\/edrv0425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:11:18Z","timestamp":1688915478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/22\/4\/425\/2423987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":264,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/edrv.22.4.0438","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}